<?xml version="1.0" encoding="UTF-8"?>
<ref id="C251">
 <label>251</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zamorano</surname>
    <given-names>JL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lancellotti</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rodriguez Munoz</surname>
    <given-names>D</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)</article-title>. 
  <source>Eur Heart J</source>
  <year>2016</year>; 
  <volume>37</volume>: 
  <fpage>2768</fpage>â€“
  <lpage>2801</lpage>. doi:
  <pub-id pub-id-type="doi">10.1093/eurheartj/ehw211</pub-id>
  <pub-id pub-id-type="pmid">27567406</pub-id>
 </mixed-citation>
</ref>
